Table 2.
Clinical and pathological variables and the expression of SKA3 in 40 cases of cervical cancer
| Parameters | Expression of SKA3 | p-value | |
|---|---|---|---|
| Low | High | ||
| Age (years) | 0.3598 | ||
| ≥ 50 | 2 (5%) | 15 (37.5%) | |
| < 50 | 4 (10%) | 19 (47.5%) | |
| TNM stage | 0.999 | ||
| I + II | 6 (15%) | 32 (80%) | |
| III + IV | 0 (0%) | 2 (5%) | |
| Clinical stage | 0.999 | ||
| I + II | 5 (12.5%) | 29 (72.5%) | |
| III + IV | 1 (2.5%) | 5 (12.5%) | |